Espinoza Octavio
CIK 1905248
Transactions on file
30
Open-market buys
2
Win rate (buys)
100%
2 scored
Avg % since filing (buys)
+191.5%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 2026-08-12 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Sale | 31,641 | $9.24M | +3.9% | open → |
| 2026-08-14 | 2026-08-12 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 3,348 | $230.1K | +341.6% | open → |
| 2026-08-14 | 2026-08-12 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 7,171 | $410.3K | +430.5% | open → |
| 2026-08-14 | 2026-08-12 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 2,869 | $159.9K | +444.4% | open → |
| 2026-08-14 | 2026-08-12 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 2,074 | $145.3K | +333.4% | open → |
| 2026-08-14 | 2026-08-12 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 16,179 | $854.9K | +474.4% | open → |
| 2026-07-06 | 2026-06-30 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Other | 17 | $2.7K | +88.9% | open → |
| 2026-05-28 | 2026-05-27 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 972 | $51.4K | +474.4% | open → |
| 2026-05-28 | 2026-05-27 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 764 | $48.6K | +377.1% | open → |
| 2025-02-19 | 2025-02-14 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Grant | 7,390 | $0.00 | — | open → |
| 2025-02-19 | 2025-02-14 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Tax | 2,757 | $330.8K | +152.9% | open → |
| 2025-02-19 | 2025-02-14 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Grant | 5,429 | $0.00 | — | open → |
| 2025-02-19 | 2025-02-15 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Tax | 1,221 | $146.5K | +152.9% | open → |
| 2025-02-19 | 2025-02-15 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Tax | 782 | $93.8K | +152.9% | open → |
| 2025-02-19 | 2025-02-15 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Tax | 1,024 | $122.9K | +152.9% | open → |
| 2025-02-19 | 2025-02-14 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Tax | 3,803 | $456.4K | +152.9% | open → |
| 2025-03-06 | 2025-03-04 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Sale | 5,000 | $575.1K | +163.9% | open → |
| 2025-03-06 | 2025-03-04 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Grant | 7,484 | $0.00 | — | open → |
| 2025-05-13 | 2025-05-09 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Buy | 500 | $52.2K | +190.7% | open → |
| 2025-05-13 | 2025-05-09 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Buy | 1,000 | $103.9K | +192.2% | open → |
| 2026-03-13 | 2026-03-11 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Sale | 3,057 | $687.8K | +34.9% | open → |
| 2026-03-13 | 2026-03-11 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 2,405 | $222.8K | +227.6% | open → |
| 2025-12-18 | 2025-12-16 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 181 | $18.7K | +193.5% | open → |
| 2025-12-18 | 2025-12-16 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 652 | $60.4K | +227.6% | open → |
| 2025-12-18 | 2025-12-16 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 285 | $18.1K | +377.1% | open → |
| 2025-12-18 | 2025-12-16 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 69 | $3.9K | +430.5% | open → |
| 2025-12-18 | 2025-12-16 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Exer. | 1,194 | $63.1K | +474.4% | open → |
| 2025-12-16 | 2025-12-12 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Sale | 1,804 | $339.7K | +61.2% | open → |
| 2025-12-09 | 2025-12-05 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Tax | 1,862 | $344.2K | +64.2% | open → |
| 2025-07-02 | 2025-06-30 | LGND LIGAND PHARMACEUTICALS INC | Officer Chief Financial Officer | Other | 224 | $20.4K | +233.3% | open → |
